Prediabetes awareness among Southeastern European physicians
Visnja Kokic1,2, Slaven Kokic1, Mladen Krnic1,2
1School of Medicine, University of Split, Split, Croatia.
Journal of Diabetes Investigation
|August 31, 2017
Summary
Physician knowledge of prediabetes (PD) is poor in Southeastern Europe. Targeted educational programs are needed to improve the early detection and management of PD, preventing progression to type 2 diabetes mellitus.
Area of Science:
- Endocrinology
- Public Health
- Medical Education
Background:
- Prediabetes (PD) is a critical transitional stage preceding type 2 diabetes mellitus.
- Early detection and intervention in PD can prevent diabetes complications.
- Growing prevalence of PD necessitates improved healthcare provider knowledge.
Purpose of the Study:
- To evaluate the existing knowledge of prediabetes among various medical professionals in Southeastern Europe.
- To identify potential gaps in understanding PD definitions and criteria.
Main Methods:
- A questionnaire-based study was conducted among general practitioners, residents, and specialists in Southeastern Europe.
- The study assessed knowledge regarding prediabetes and type 2 diabetes mellitus criteria.
Main Results:
- 397 physicians completed the survey, with diabetologists demonstrating the highest correct answer rate (69%).
- Overall correct answers for PD definition and numerical criteria (impaired fasting glucose, impaired glucose tolerance) were low (46.6%, 46.3%, 46.8%).
- Younger physicians showed significantly better knowledge of PD and type 2 diabetes mellitus criteria (P < 0.001).
Conclusions:
- Physician knowledge of prediabetes in Southeastern Europe is inadequate.
- There is a clear need for enhanced educational initiatives focused on prediabetes within the region.
- Improved understanding of PD is crucial for effective prevention of type 2 diabetes mellitus.
More Related Videos
10:07Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature
Published on: December 26, 2017
14.1K
15:18Near Infrared Optical Projection Tomography for Assessments of β-cell Mass Distribution in Diabetes Research
Published on: January 12, 2013
17.0K
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
5.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.2K
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.5K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K
01:15Diabetes: Management and Pharmacotherapy
1.2K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
01:22Diabetes Mellitus: Overview and Type I Subtype
5.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.6K
01:20Pathophysiology of Diabetes
3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
721
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
721